|
[1]
|
Sharma A, Ahmad Farouk I, Lal SK. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses 2021;13(2):202. http://dx.doi.org/10.3390/v13020202CrossRef
|
|
[2]
|
Salzberger B, Buder F, Lampl B, Ehrenstein B, Hitzenbichler F, Holzmann T, et al. Epidemiology of SARS-CoV-2. Infection 2021;49(2):233 − 9. http://dx.doi.org/10.1007/s15010-020-01531-3CrossRef
|
|
[3]
|
Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, et al. A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. FEBS J 2020;287(17):3633 − 50. http://dx.doi.org/10.1111/febs.15375CrossRef
|
|
[4]
|
Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates. Philos Trans Roy Soc B Biol Sci 2021;376(1829):20200265. http://dx.doi.org/10.1098/rstb.2020.0265CrossRef
|
|
[5]
|
Wikramaratna PS, Paton RS, Ghafari M, Lourenço J. Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR. Eurosurveillance 2020;25(50):2000568. http://dx.doi.org/10.2807/1560-7917.ES.2020.25.50.2000568CrossRef
|
|
[6]
|
Xue GH, Li SL, Zhang WW, Du B, Cui JH, Yan C, et al. Reverse-transcription recombinase-aided amplification assay for rapid detection of the 2019 novel coronavirus (SARS-CoV-2). Anal Chem 2020;92(14):9699 − 705. http://dx.doi.org/10.1021/acs.analchem.0c01032CrossRef
|
|
[7]
|
Padoan A, Cosma C, Sciacovelli L, Faggian D, Plebani M. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. Clin Chem Lab Med 2020;58(7):1081 − 8. http://dx.doi.org/10.1515/cclm-2020-0443CrossRef
|
|
[8]
|
Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev 2021;34(3):e00228 − 20. http://dx.doi.org/10.1128/CMR.00228-20CrossRef
|
|
[9]
|
Shahrajabian MH, Sun WL, Cheng Q. Different methods for molecular and rapid detection of human novel coronavirus. Curr Pharm Des 2021;27(25):2893 − 903. http://dx.doi.org/10.2174/1381612827666210604114411CrossRef
|
|
[10]
|
Wang J, Cai K, He X, Shen X, Wang J, Liu J, et al. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA. Clin Microbiol Infect 2020;26(8):1076 − 81. http://dx.doi.org/10.1016/j.cmi.2020.05.007CrossRef
|
|
[11]
|
Zheng YZ, Chen JT, Li J, Wu XJ, Wen JZ, Liu XZ, et al. Reverse transcription recombinase-aided amplification assay with lateral flow dipstick assay for rapid detection of 2019 novel coronavirus. Front Cell Infect Microbiol 2021;11:1 − 7. http://dx.doi.org/10.3389/fcimb.2021.613304CrossRef
|
|
[12]
|
Wu T, Ge YY, Zhao KC, Zhu XJ, Chen Y, Wu B, et al. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Virology 2020;549:1 − 4. http://dx.doi.org/10.1016/j.virol.2020.07.006CrossRef
|
|
[13]
|
Pan BH, Ji ZW, Sakkiah S, Guo WJ, Liu J, Patterson TA, et al. Identification of epidemiological traits by analysis of SARS−CoV−2 sequences. Viruses 2021;13(5):764. http://dx.doi.org/10.3390/v13050764CrossRef
|
|
[14]
|
Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P. COVID-19 pandemic: a review of the global lockdown and its far-reaching effects. Sci Prog 2021;104(2):368504211019854. http://dx.doi.org/10.1177/00368504211019854CrossRef
|
|
[15]
|
Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis -A review of current methods. Biosens Bioelectron 2021;172:112752. http://dx.doi.org/10.1016/j.bios.2020.112752CrossRef
|